Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Immunology Research, enter your email address in the box below.

Journal of Immunology Research
Volume 2017, Article ID 3972706, 8 pages
https://doi.org/10.1155/2017/3972706
Research Article

High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study

Sevgi Akarsu, Ozlem Ozbagcivan, Fatma Semiz, and Sebnem Aktan

Department of Dermatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey

Correspondence should be addressed to Ozlem Ozbagcivan; rt.ude.ued@navicgabzo.melzo

Received 23 September 2016; Accepted 7 December 2016; Published 3 January 2017

Academic Editor: Margarete D. Bagatini

Copyright © 2017 Sevgi Akarsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Z. Hejazi and V. P. Werth, “Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment,” American Journal of Clinical Dermatology, vol. 17, no. 2, pp. 135–146, 2016. View at Publisher · View at Google Scholar
  2. V. P. Werth, “Cutaneous lupus: insights into pathogenesis and disease classification,” Bulletin of the NYU Hospital for Joint Diseases, vol. 65, no. 3, pp. 200–204, 2007. View at Google Scholar · View at Scopus
  3. M. G. Kirchhof and J. P. Dutz, “The immunopathology of cutaneous lupus erythematosus,” Rheumatic Disease Clinics of North America, vol. 40, no. 3, pp. 455–474, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Hesselvig, O. Ahlehoff, L. Dreyer, G. Gislason, and K. Kofoed, “Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study,” Lupus, vol. 26, no. 1, pp. 48–53, 2017. View at Publisher · View at Google Scholar
  5. B. Zöller, X. Li, J. Sundquist, and K. Sundquist, “Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden,” PLoS ONE, vol. 7, no. 3, Article ID e33442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Singh, C. S. Crowson, S. Singh et al., “Risk of cerebrovascular accidents and ischemic heart disease in cutaneous lupus erythematosus: a population-based cohort study,” Arthritis Care & Research, vol. 68, no. 11, pp. 1664–1670, 2016. View at Publisher · View at Google Scholar
  7. J. M. Sabio, M. Zamora-Pasadas, J. Jiménez-Jáimez et al., “Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain,” Lupus, vol. 17, no. 9, pp. 849–859, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Parker, Y. Ahmad, J. Shelmerdine et al., “An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus,” Lupus, vol. 20, no. 14, pp. 1459–1465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. P. Chung, I. Avalos, A. Oeser et al., “High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors,” Annals of the Rheumatic Diseases, vol. 66, no. 2, pp. 208–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. S. Nascimento, C. R. D. C. Quaio, N. A. Sinicato, S. Appenzeller, and J. F. De Carvalho, “Aspects of atherosclerosis and metabolic syndrome in lupus erythematosus,” Acta Reumatologica Portuguesa, vol. 35, no. 3, pp. 294–300, 2010. View at Google Scholar · View at Scopus
  11. C. C. Mok, W. L. Poon, J. P. S. Lai et al., “Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 39, no. 1, pp. 42–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Negrón, M. J. Molina, A. M. Mayor, V. E. Rodríguez, and L. M. Vilá, “Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico,” Lupus, vol. 17, no. 4, pp. 348–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. D. C. Medeiros, Í. M. Xavier de Oliveira, and Á. T. M. Ribeiro, “Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age,” Rheumatology International, vol. 36, no. 1, pp. 117–124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Castejon, C. Jimenez-Ortiz, S. Rosado, P. Tutor-Ureta, S. Mellor-Pita, and M. Yebra-Bango, “Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus,” Lupus, vol. 25, no. 2, pp. 129–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Demir, B. Artim-Esen, Y. Şahinkaya et al., “Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients,” Lupus, vol. 25, no. 2, pp. 177–184, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. C. L. Gabriel, P. B. Smith, Y. V. Mendez-Fernandez, A. J. Wilhelm, A. M. Ye, and A. S. Major, “Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus,” American Journal of Physiology-Endocrinology and Metabolism, vol. 303, no. 11, pp. E1313–E1324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. A. Miot, L. D. B. Miot, and G. R. Haddad, “Association between discoid lupus erythematosus and cigarette smoking: a case-control study,” Dermatology, vol. 211, no. 2, pp. 118–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Albrecht, L. Taylor, J. A. Berlin et al., “The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus,” Journal of Investigative Dermatology, vol. 125, no. 5, pp. 889–894, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Bein, E. Kuehn, A. M. Meuth et al., “Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 6, pp. 652–659, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. G. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. H. Eckel, K. G. M. M. Alberti, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 375, no. 9710, pp. 181–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. W. F. Wilson, R. B. D'Agostino, H. Parise, L. Sullivan, and J. B. Meigs, “Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus,” Circulation, vol. 112, no. 20, pp. 3066–3072, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Padhi and Garima, “Metabolic syndrome and skin: psoriasis and beyond,” Indian Journal of Dermatology, vol. 58, no. 4, pp. 299–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. W. Piette, K. P. Foering, A. Y. Chang et al., “Impact of smoking in cutaneous lupus erythematosus,” Archives of Dermatology, vol. 148, no. 3, pp. 317–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. B. C. Böckle and N. T. Sepp, “Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients,” Lupus, vol. 24, no. 7, pp. 669–674, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. P. Bewley, “Cutaneous lupus erythematosus is strongly associated with psychiatric disease,” British Journal of Dermatology, vol. 174, no. 5, pp. 958–959, 2016. View at Publisher · View at Google Scholar
  28. I. Jalenques, F. Rondepierre, C. Massoubre et al., “High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case-control study,” British Journal of Dermatology, vol. 174, no. 5, pp. 1051–1060, 2016. View at Publisher · View at Google Scholar
  29. J. Achtman, M. A. Kling, R. Feng, J. Okawa, and V. P. Werth, “A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis,” Journal of the American Academy of Dermatology, vol. 74, no. 2, pp. 377–379, 2016. View at Publisher · View at Google Scholar
  30. M. Maes, M. Kubera, E. Obuchowiczwa, L. Goehler, and J. Brzeszcz, “Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways,” Neuroendocrinology Letters, vol. 32, no. 1, pp. 7–24, 2011. View at Google Scholar · View at Scopus